Antiproliferative Activity and in Vivo Toxicity of Double-Point Modified Analogs of 1,25-Dihydroxyergocalciferol

An ATRActive future for differentiation therapy in AML

(2015) Daniel E. Johnson et al.   BLOOD REVIEWS

Double Point Modified Analogs of Vitamin D as Potent Activators of Vitamin D Receptor

(2015) Sharmin Nadkarni et al.   CURRENT PHARMACEUTICAL DESIGN

How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia

(2014) M. A. Sanz et al.   BLOOD

Monocytic differentiation induced by side-chain modified analogs of vitamin D in ex vivo cells from patients with acute myeloid leukemia

(2014) Hanna Baurska et al.   LEUKEMIA RESEARCH

Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment

(2014) MAGDALENA MILCZAREK et al.   ONCOLOGY REPORTS

Cheburator Software for Automatically Calculating Drug Inhibitory Concentrations from In Vitro Screening Assays

(2014) Dmitry Nevozhay   PLoS One

Vitamin D analogs enhance the anticancer activity of 5-fluorouracil in an in vivomouse colon cancer model

(2013) Magdalena Milczarek et al.   BMC CANCER

Recent Developments of 2-Substituted Analogs of 1,25(OH)2D3

(2013) Can-Fei Zhang et al.   CURRENT MEDICINAL CHEMISTRY

Synthesis and crystallographic study of 1,25-dihydroxyergocalciferol analogs

(2013) Anita Pietraszek et al.   STEROIDS

Synthesis and Biological Activity of Diastereomeric and Geometric Analogs of Calcipotriol, PRI-2202 and PRI-2205, Against Human HL-60 Leukemia and MCF-7 Breast Cancer Cells

(2013) Magdalena Milczarek et al.   Cancers

Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiation

(2012) Elżbieta Gocek et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Structure–function analysis of vitamin D2 analogs as potential inducers of leukemia differentiation and inhibitors of prostate cancer proliferation

(2011) H. Baurska et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

19-nor-1α,25-Dihydroxyvitamin D2(Paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo

(2010) Gary G. Schwartz et al.   CANCER BIOLOGY & THERAPY

Nuclear translocation of the 1,25D3-MARRS (membrane associated rapid response to steroids) receptor protein and NFκB in differentiating NB4 leukemia cells

(2010) Wenqing Wu et al.   EXPERIMENTAL CELL RESEARCH

Involvement of 1,25D3-MARRS (membrane associated, rapid response steroid-binding), a novel vitamin D receptor, in growth inhibition of breast cancer cells

(2009) Cynthia L. Richard et al.   EXPERIMENTAL CELL RESEARCH

Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model

(2008) Joanna Wietrzyk et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Vitamin D analogs: Therapeutic applications and mechanisms for selectivity

(2008) Alex J. Brown et al.   MOLECULAR ASPECTS OF MEDICINE